Maddon; Paul J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maddon; Paul J..The latest application filed is for "ace2- and tmprss2-targeted compositions and methods for treating covid-19".

Company Profile

4.42.68

Maddon; Paul J. - Scarsdale NY
Maddon; Paul J. - Elmsford NY
Maddon; Paul J. - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
ACE2- and TMPRSS2-Targeted Compositions and Methods for Treating COVID-19 App 20220098283 - Maddon; Paul J.	2022-03-31
ACE2-Targeted Compositions and Methods for Treating COVID-19 App 20220056153 - Maddon; Paul J.	2022-02-24
Bispecific Antibody Compositions and Methods for Treating COVID-19 App 20220056154 - Maddon; Paul J.	2022-02-24
Psma Antibody-drug Conjugates App 20210023094 - Ma; Dangshe ; et al.	2021-01-28
Methods For Reducing Viral Load In Hiv-1 Infected Patients App 20200306372 - Olson; William C. ; et al.	2020-10-01
Methods for reducing viral load in HIV-1 infected patients Grant 10,500,274 - Olson , et al. Dec	2019-12-10
Screening Methods For Identifying And Treating Hiv-1 Infected Patient Sub-populations Suitable For Long Term Anti-ccr5 Agent Therapy App 20190085086 - Maddon; Paul J. ; et al.	2019-03-21
PSMA antibodies and uses thereof Grant 9,695,248 - Maddon , et al. July 4, 2	2017-07-04
Psma Antibodies And Uses Thereof App 20150197577 - Maddon; Paul J. ; et al.	2015-07-16
Methods For Inhibiting Hiv-1 Replication Involving The Administration Of An Anti-ccr5 Receptor Monoclonal Antibody And Small Molecule Ccr5 Receptor Antagonist App 20140377259 - Olson; William C. ; et al.	2014-12-25
Psma Antibodies And Uses Thereof App 20140286859 - Maddon; Paul J. ; et al.	2014-09-25
Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist Grant 8,821,877 - Olson , et al. September 2, 2	2014-09-02
Methods For Reducing Viral Load In Hiv-1 Infected Patients App 20130216526 - Olson; William C. ; et al.	2013-08-22
Method For Preventing Hiv-1 Infection Of Cd4+ Cells App 20130211043 - Allaway; Graham P. ; et al.	2013-08-15
PSMA antibodies and uses thereof Grant 8,470,330 - Maddon , et al. June 25, 2	2013-06-25
Compositions of PSMA antibodies Grant 8,114,965 - Maddon , et al. February 14, 2	2012-02-14
Methods For Reducing Viral Load in HIV-1 Infected Patients App 20110200592 - OLSON; WILLIAM C. ; et al.	2011-08-18
Psma Antibodies And Uses Thereof App 20110165081 - Schulke; Norbert ; et al.	2011-07-07
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion Grant 7,935,797 - Allaway , et al. May 3, 2	2011-05-03
Soluble stabilized trimeric hiv env proteins and uses thereof App 20110076298 - Olson; William C. ; et al.	2011-03-31
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion Grant 7,901,685 - Allaway , et al. March 8, 2	2011-03-08
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion Grant 7,862,994 - Allaway , et al. January 4, 2	2011-01-04
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists Grant 7,858,298 - Allaway , et al. December 28, 2	2010-12-28
Anti-CCR5 antibody Grant 7,851,600 - Olson , et al. December 14, 2	2010-12-14
PSMA antibodies and protein multimers Grant 7,850,971 - Maddon , et al. December 14, 2	2010-12-14
Methods for reducing viral load in HIV-1 infected patients App 20100178290 - Olson; William C. ; et al.	2010-07-15
Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors Grant 7,736,649 - Olson , et al. June 15, 2	2010-06-15
Anti-CCR5 antibody Grant 7,666,419 - Olson , et al. February 23, 2	2010-02-23
Stabilized viral envelope proteins and uses thereof Grant 7,592,014 - Binley , et al. September 22, 2	2009-09-22
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell App 20090155774 - Allaway; Graham P. ; et al.	2009-06-18
Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins Grant 7,479,553 - Binley , et al. January 20, 2	2009-01-20
Compositions of PSMA antibodies App 20080286284 - Maddon; Paul J. ; et al.	2008-11-20
Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex App 20080274134 - Schulke; Norbert ; et al.	2008-11-06
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Grant 7,446,177 - Olson , et al. November 4, 2	2008-11-04
Methods for reducing viral load in HIV-1-infected patients App 20080241135 - Olson; William C. ; et al.	2008-10-02
Compounds Capable Of Inhibiting Hiv-1 Infection App 20080226651 - Litwin; Virginia M. ; et al.	2008-09-18
Method for preventing HIV-1 infection of CD4 cells App 20080187539 - Allaway; Graham P. ; et al.	2008-08-07
Method for preventing HIV-1 infection of CD4+ Cells App 20080138897 - Allaway; Graham P. ; et al.	2008-06-12
Anti-CCR5 antibody App 20080107595 - Olson; William C. ; et al.	2008-05-08
Compounds capable of inhibiting HIV-1 infection Grant 7,345,153 - Litwin , et al. March 18, 2	2008-03-18
Nucleic acids encoding polypeptides of anti-CCR5 antibodies App 20080015348 - Olson; William C. ; et al.	2008-01-17
Compositions comprising anti-CCR5 antibody App 20070274986 - Olson; William C. ; et al.	2007-11-29
Anti-CCR5 antibodies App 20070231327 - Olson; William C. ; et al.	2007-10-04
PSMA antibody-drug conjugates App 20070160617 - Ma; Dangshe ; et al.	2007-07-12
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion App 20070048820 - Allaway; Graham P. ; et al.	2007-03-01
Anti-CCR5 antibody App 20070031408 - Olson; William C. ; et al.	2007-02-08
Compounds capable of inhibiting HIV-1 infection App 20070025983 - Litwin; Virginia M. ; et al.	2007-02-01
Methods for reducing viral load in HIV-1-infected patients App 20070026441 - Olson; William C. ; et al.	2007-02-01
Compositions and methods for inhibition of HIV-1 infection App 20070020280 - Olson; William C. ; et al.	2007-01-25
Compositions and methods for inhibition of HIV-1 infection Grant 7,138,119 - Olson , et al. November 21, 2	2006-11-21
Methods for inhibiting HIV-1 infection App 20060233798 - Olson; William C. ; et al.	2006-10-19
Anti-CCR5 antibody Grant 7,122,185 - Olson , et al. October 17, 2	2006-10-17
Methods for inhibiting HIV-1 infection Grant 7,118,859 - Litwin , et al. October 10, 2	2006-10-10
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20060198855 - Olson; William C. ; et al.	2006-09-07
Uses of a chemokine receptor for inhibiting HIV-1 infection App 20060194244 - Allaway; Graham P. ; et al.	2006-08-31
Cells expressing a CD4-IgG2 chimeric heterotetramer Grant 7,070,991 - Beaudry , et al. July 4, 2	2006-07-04
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion App 20060140977 - Allaway; Graham P. ; et al.	2006-06-29
Methods for inhibiting HIV-1 infection Grant 7,060,273 - Olson , et al. June 13, 2	2006-06-13
Stabilized viral envelope proteins and uses thereof App 20060094049 - Binley; James M. ; et al.	2006-05-04
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Grant 7,022,323 - Olson , et al. April 4, 2	2006-04-04
Stabilized viral envelope proteins and uses thereof Grant 7,022,324 - Binley , et al. April 4, 2	2006-04-04
Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods App 20060051373 - Olson; William C. ; et al.	2006-03-09
Method for preventing HIV-1 infection of CD4+ cells App 20060029932 - Allaway; Graham P. ; et al.	2006-02-09
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same Grant 6,972,126 - Allaway , et al. December 6, 2	2005-12-06
PSMA formulations and uses thereof App 20050215472 - Schulke, Norbert ; et al.	2005-09-29
Human immunodeficiency virus envelope clycoprotein mutants and uses thereof App 20050089526 - Moore, John P. ; et al.	2005-04-28
Combination therapy for constipation App 20040259899 - Sanghvi, Suketu P. ; et al.	2004-12-23
Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto App 20040228869 - Olson, William C. ; et al.	2004-11-18
Stabilized viral envelope proteins and uses thereof App 20040224308 - Binley, James M. ; et al.	2004-11-11
PSMA formulations and uses thereof App 20040161776 - Maddon, Paul J. ; et al.	2004-08-19
Anti-cd19 immunotoxins App 20040136908 - Olson, William C. ; et al.	2004-07-15
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Grant 6,737,267 - Maddon , et al. May 18, 2	2004-05-18
Uses of a chemokine receptor for inhibiting HIV-1 infection App 20040086528 - Allaway, Graham P. ; et al.	2004-05-06
Compositions and methods for inhibition of HIV-1 infection App 20040062767 - Olson, William C. ; et al.	2004-04-01
Stabilized viral envelope proteins and uses thereof Grant 6,710,173 - Binley , et al. March 23, 2	2004-03-23
PSMA antibodies and protein multimers App 20040033229 - Maddon, Paul J. ; et al.	2004-02-19
Compositions and methods for inhibition of HIV-1 infection Grant 6,692,745 - Olson , et al. February 17, 2	2004-02-17
Derivatives of soluble T-4 App 20040013683 - Maddon, Paul J. ; et al.	2004-01-22
Derivatives of soluble T-4 Grant 6,673,896 - Maddon , et al. January 6, 2	2004-01-06
Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection App 20030232745 - Olson, William C. ; et al.	2003-12-18
Anti-CCR5 antibody App 20030228306 - Olson, William C. ; et al.	2003-12-11
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20030134297 - Olson, William C. ; et al.	2003-07-17
Compositions and methods for inhibition of hiv-1 infection App 20030082185 - Olson, William C. ; et al.	2003-05-01
Stabilized viral envelope proteins and uses thereof App 20030052839 - Binley, James M. ; et al.	2003-03-20
Methods For Using Resonance Energy Transfer- Based Assay Of Hiv-1 Envelope Gylcoprotein-mediated Membrane Fusion, And Kits For Practicing Same App 20030044770 - ALLAWAY, GRAHAM P. ; et al.	2003-03-06
Methods for inhibiting HIV-1 infection App 20030044411 - Olson, William C. ; et al.	2003-03-06
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection App 20030013081 - Olson, William C. ; et al.	2003-01-16
Method for preventing HIV-1 infection of CD4+ cells App 20020155429 - Allaway, Graham P. ; et al.	2002-10-24
Methods for inhibiting HIV-1 infection App 20020146415 - Olson, William C. ; et al.	2002-10-10
CD4-gamma2 and CD4-IGG2 chimeras Grant 6,451,313 - Maddon , et al. September 17, 2	2002-09-17
Compositions and methods for inhibition of HIV-1 infection App 20020106374 - Olson, William C. ; et al.	2002-08-08
Cd4-gamma2 And Cd4-igg2 Chimeras App 20020098191 - BEAUDRY, GARY A. ; et al.	2002-07-25
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof App 20020052481 - Maddon, Paul J. ; et al.	2002-05-02
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell App 20020045161 - Allaway, Graham P. ; et al.	2002-04-18
Method for preventing HIV-1 infection of CD4+ cells Grant 6,344,545 - Allaway , et al. February 5, 2	2002-02-05
Compounds capable of inhibiting HIV-1 infection App 20010046512 - Litwin, Virginia M. ; et al.	2001-11-29
Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion Grant 6,261,763 - Allaway , et al. July 17, 2	2001-07-17
Method for preventing HIV-1 infection of CD4.sup.+ cells Grant 6,107,019 - Allaway , et al. August 22, 2	2000-08-22
DNA encoding the T cell surface protein T4 and use of fragments of T4 in the treatment of AIDS Grant 6,093,539 - Maddon , et al. July 25, 2	2000-07-25
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Grant 6,034,223 - Maddon , et al. March 7, 2	2000-03-07
DNA encoding the T cell surface protein T4 and use of fragments of T4 in the treatment of AIDS Grant 5,958,678 - Maddon , et al. September 28, 1	1999-09-28
Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same Grant 5,817,767 - Allaway , et al. October 6, 1	1998-10-06
Soluble forms of the T cell surface protein CD4 Grant 5,126,433 - Maddon , et al. June 30, 1	1992-06-30
Derivatives of soluble T-4 Grant 5,110,906 - Maddon , et al. May 5, 1	1992-05-05

Company Registrations

NCAGE Code	4CE44	MADDON PAUL J
CAGE Code	4CE44	MADDON, PAUL J
DUNS	621549315	MADDON, PAUL J
SEC	0001250313	MADDON PAUL J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.